Stock Report

Download full stock data and analysis for free Last Updated: 10-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

CORONA Remedies Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: CORONA | BSE: 544644

₹2,024.00

up-down-arrow ₹30.50 (1.53%)

As on 09-Oct-2026IST

Market cap

info icon

₹12,380 Cr

Revenue (TTM)

info icon

₹1,479 Cr

P/E Ratio

info icon

62.2

P/B Ratio

info icon

15.3

Div. Yield

info icon

0.5 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 19.64 21.90 18.16 16.65 19.49
EBIT 54.44 31.27 23.39 33.31 23.35
Net Profit 32.61 30.11 28.76 29.71 21.45
EPS 32.61 30.11 20.14 29.71 17.14
Book Value -- -- 23.15 22.29 13.04
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 15.8811.8818.5718.2116.95
Net Margin info 11.458.7613.3213.0912.43
Return on equity info 25.0619.6630.3327.3627.50
Return on Capital info 30.0724.27--31.7432.59
Return on Assets info 14.5011.4732.9515.9915.79
Debt to Equity (x) info ----0.000.190.10

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
31.74
32.59
25.93
28.03
Peer Median
--
21.34
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

30.33

Higher than Peers by 14.88

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
30.33
27.36
27.50
20.36
20.79
Peer Median
15.45
18.24
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

32.95

Higher than Peers by 22.40

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
32.95
15.99
15.79
11.77
12.82
Peer Median
10.55
10.51
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

18.57

Higher than Peers by 0.91

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
18.57
18.21
16.95
12.47
12.20
Peer Median
17.65
18.18
18.93
21.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

13.32

Lower than Peers by 0.64

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
13.32
13.09
12.43
8.86
9.53
Peer Median
13.95
13.32
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
16.17
15.88
11.45
11.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

18.16

Higher than Peers by 6.23

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
18.16
17.28
17.94
14.75
--
Peer Median
11.93
11.99
10.90
13.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

23.39

Higher than Peers by 1.43

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
23.39
26.01
60.39
17.22
--
Peer Median
21.96
15.05
15.01
23.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

28.76

Higher than Peers by 5.19

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
28.76
23.88
65.11
6.56
--
Peer Median
23.56
11.28
14.80
30.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

20.14

Higher than Peers by 0.45

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
20.14
23.88
65.11
6.56
--
Peer Median
19.69
12.16
14.27
29.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
23.18
26.21
17.60
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
0.19
0.10
0.28
0.01
Peer Median
0.01
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
0.17
0.02
0.06
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.96

Lower than Peers by 1.05

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
0.96
0.97
1.30
1.24
1.74
Peer Median
2.02
1.93
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.62

Lower than Peers by 0.87

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
0.62
0.70
0.91
0.88
1.23
Peer Median
1.49
1.52
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

34.89

Higher than Peers by 15.87

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
34.89
35.49
19.73
9.21
26.98
Peer Median
19.02
19.95
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

9.84

Lower than Peers by 11.32

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
9.84
10.37
9.89
9.85
9.84
Peer Median
21.16
19.87
21.77
20.10
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

2.45

Higher than Peers by 1.73

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
2.45
1.19
1.24
1.35
1.36
Peer Median
0.73
0.78
0.76
0.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
34.91
33.89
32.89
35.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
33.67
35.38
35.85
42.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
203.24
198.93
167.89
163.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
--
-134.66
-129.66
-99.14
-85.10
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

62.20

Higher than Peers by 30.97

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
62.20
51.41
--
--
--
Peer Median
31.24
31.99
26.81
39.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

15.34

Higher than Peers by 10.47

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
15.34
12.74
--
--
--
Peer Median
4.87
5.03
4.65
6.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.49

Lower than Peers by 0.12

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
0.49
0.64
--
--
--
Peer Median
0.61
0.62
0.61
0.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

37.98

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
37.98
31.62
0.22
0.78
-0.10
Peer Median
--
25.51
27.02
34.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

12,380

Lower than Peers by 5,055

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
CORONA Remedies
12,380
9,517
--
--
--
Peer Median
17,436
15,424
20,914
25,297
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...